Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”-Reference-Cited by-同舟云学术

Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”

Published:2020-06 Issue:6 Volume:82 Page:e215
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Lebwohl Mark,Rivera-Oyola Ryan,Murrell Dedee F.

Funder

AbbVie

Amgen

Eli Lilly

Janssen Research & Development

Novartis

Ortho Dermatologics

UCB

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: a word of caution;Kansal;J Am Acad Dermatol,2020

2. Should biologics for psoriasis be interrupted in the era of COVID-19?;Lebwohl;J Am Acad Dermatol,2020

3. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis;Puel;Curr Opin Allergy Clin Immunol,2012

4. Mendelian susceptibility to mycobacterial infection in man;Altare;Curr Opin Immunol,1998

5. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies;Conti;J Biol Regul Homeost Agents,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Syphilis for dermatologists – current concepts;Clinics in Dermatology;2023-12

2. Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?;Clinics in Dermatology;2021-01

3. Improvement of SARS‐CoV‐2 symptoms following Guselkumab injection in a psoriatic patient;Journal of the European Academy of Dermatology and Venereology;2020-06-04

4. Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”;Journal of the American Academy of Dermatology;2020-06